$0.0134
At close: Apr 30, 7:41 PM EDT
$0.0155
0.0021015.67%
After Hours: Apr 30, 7:41 PM EDT
Comments
Loading...
Revelation Biosciences Analyst Ratings and Price Targets | NASDAQ:REVBW | Benzinga
Revelation Biosciences Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for Revelation Biosciences Corp from these most-recent analyst ratings.
Analyst Ratings for Revelation Biosciences
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for Revelation Biosciences (REVBW) stock?
There is no price target for Revelation Biosciences
What is the most recent analyst rating for Revelation Biosciences (REVBW)?
There is no analyst for Revelation Biosciences
When was the last upgrade for Revelation Biosciences (REVBW)?
There is no last upgrade for Revelation Biosciences
When was the last downgrade for Revelation Biosciences (REVBW)?
There is no last downgrade for Revelation Biosciences.
When is the next analyst rating going to be posted or updated for Revelation Biosciences (REVBW)?
There is no next analyst rating for Revelation Biosciences.
Is the Analyst Rating Revelation Biosciences (REVBW) correct?
There is no next analyst rating for Revelation Biosciences.
Browse analyst ratings and price targets on all stocks.
